Personalized, Safe, and Accessible Oncological Care
Maple Med Global is an international healthcare coordination center that connects patients with world-class oncology hospitals across multiple countries.
Our mission is to help patients access the right treatment, at the right time, in the right place — and at the right cost.
We are not bound to a single hospital or country. Instead, we collaborate with a global network of accredited cancer centers, objectively comparing medical, technological, and financial factors to find the most suitable option for each patient.
Why Choose Global Oncology Options?
Successful cancer treatment requires more than advanced drugs or equipment — it depends on the right specialists, technology, and timely access.
Each country has unique strengths: some excel in nuclear medicine or theranostics, others in genomic oncology or cost efficiency.
Maple Med Global evaluates all these dimensions on your behalf, ensuring you receive the most effective and safe treatment possible.
What sets Maple Med Global apart:
-
Immediate access to treatment without waiting lists.
-
Accredited cancer centers that meet international quality standards.
-
Advanced technologies including proton therapy, theranostic nuclear medicine (Lu-177/Ac-225), MR-LINAC, CyberKnife, immunotherapy, CAR-T, and genomic oncology.
-
Transparent, cost-effective treatment options (no hidden fees).
-
End-to-end coordination with dedicated medical advisors.
Global Cancer Treatment Destinations
At Maple Med Global, we collaborate directly with leading oncology centers in selected countries that combine cutting-edge medical technology with cost-effective accessibility.
These destinations were carefully chosen for their proven expertise in advanced cancer care, including MR-LINAC, CyberKnife, Proton Therapy, Theranostic Nuclear Medicine, CAR-T cell therapy, and Genomic Oncology, all delivered at globally competitive prices.
Each country offers unique strengths in oncology — from innovation and infrastructure to experience and affordability — ensuring that every patient can access the highest quality treatment without financial or geographical barriers.
Türkiye
Türkiye is recognized for its world-class oncology centers that combine cutting-edge technology with internationally accredited standards.
Türkiye’s oncology centers perform advanced procedures such as MR-LINAC, CyberKnife M6, Radixact/TomoTherapy, and theranostic nuclear therapies like Lutetium-177 and Actinium-225.
Genetic and molecular profiling, as well as robotic surgery, are also widely available.
The key advantage is immediate access to high-technology care without long waiting times and at significantly lower costs compared to North America or Europe.
Spain and Central Europe
European oncology institutions lead in proton therapy, molecular diagnostics, multidisciplinary tumor boards, and early-phase clinical research.
Within the EU’s unified health safety framework, these centers offer exceptional accuracy for brain, lung, and pediatric tumors.
Personalized medicine based on genomic analysis and biomarker testing is widely practiced.
India
India is one of Asia’s most comprehensive oncology hubs, offering proton therapy, immunotherapy, targeted drug programs, CAR-T cell therapy, and robotic surgery within one comprehensive system.
High patient volumes allow oncologists to gain extensive experience with rare and complex cancer types.
Combined with advanced technology and affordability, India remains a global leader in accessible precision oncology.
Mexico
Mexico hosts numerous Joint Commission International (JCI)-accredited cancer centers.
These facilities provide chemotherapy, radiotherapy, surgical oncology, and nuclear medicine following international protocols.
Its proximity to North America and cost advantage make Mexico a preferred destination for patients from Canada and the U.S.
Thailand
Thailand ranks among the top medical tourism destinations worldwide.
Its hospitals feature IMRT, SBRT, MR-LINAC, targeted therapy, and immunotherapy, supported by English-speaking medical teams.
A strong focus on patient comfort, safety, and hospitality makes Thailand a trusted choice for international cancer care.
Advanced Oncology Technologies and Treatment Approaches
Radiotherapy and Radiosurgery
IMRT (Intensity-Modulated Radiation Therapy)
IMRT is one of the most advanced forms of external beam radiation therapy.
It shapes the radiation dose to the exact 3D shape of the tumor, using computer-controlled beams that spare nearby healthy tissue.
This technique is widely used in prostate, breast, head-and-neck, and gynecological cancers, significantly reducing side effects such as fatigue or skin irritation.
VMAT (Volumetric Modulated Arc Therapy)
VMAT delivers radiation in a smooth, continuous arc around the patient, completing treatment in minutes instead of long static sessions.
This allows oncologists to deliver an accurate and uniform dose from multiple angles, improving tumor coverage and patient comfort.
It’s often preferred for complex or irregularly shaped tumors in the pelvis, chest, or brain.
SBRT / CyberKnife (Stereotactic Body Radiotherapy)
CyberKnife is a robotic radiosurgery system that delivers extremely focused, high-dose radiation to tumors that cannot be surgically removed.
It tracks even the slightest patient or tumor movement in real-time, adjusting beams automatically for sub-millimeter accuracy.
This method is ideal for lung, liver, spine, and brain tumors, offering effective treatment with no incisions and minimal recovery period.
MR-LINAC
(MRI-Guided Linear Accelerator)
MR-LINAC combines MRI imaging with radiation delivery, allowing doctors to see the tumor and surrounding organs during every treatment session.
This real-time visualization makes it possible to adapt radiation precisely as the tumor moves — for example, during breathing.
It’s especially effective for lung, liver, and pancreatic cancers, where tumor motion is a challenge.
Proton Therapy
Proton therapy uses positively charged particles instead of conventional X-rays.
These protons release their energy directly inside the tumor, stopping at a precise depth and avoiding damage to healthy tissues.
It’s ideal for brain, spinal, and pediatric cancers, and is increasingly used for patients who need radiation near sensitive organs.
.webp)
Brachytherapy (Internal Radiation Therapy)
Brachytherapy delivers radiation from inside the body by placing tiny radioactive sources directly into or next to the tumor.
This allows for a higher dose of radiation to the cancer while reducing exposure to nearby tissues.
It’s commonly used for prostate, cervical, and breast cancers, and typically involves short treatment sessions with fast recovery.
Nuclear Medicine and Theranostic Therapies
Lutetium-177
(Lu-177) Therapy
This therapy uses a radioactive isotope that attaches directly to tumor cell receptors, releasing targeted radiation from within.
It is especially effective for advanced prostate and neuroendocrine tumors that no longer respond to standard treatments.
Patients often experience tumor shrinkage and symptom relief with mild side effects.
Actinium-225
(Ac-225) Therapy
Actinium-225 delivers highly potent alpha-particle radiation that destroys cancer cells at the microscopic level while sparing healthy tissue.
Because of its strong energy and short path, it often achieves results in fewer sessions and with minimal side effects.
This new-generation therapy offers hope for patients resistant to conventional methods.
Theranostic Approach (Diagnosis + Therapy in One)
Theranostics combines diagnostic imaging and treatment in a single molecular pathway.
Using the same compound, doctors can both identify cancer cells via PET/CT and treat them with targeted radiation.
This personalized approach ensures that each patient receives the right therapy for their specific tumor biology.
Immunotherapy and Targeted Treatments
Checkpoint Inhibitors
These drugs help the immune system “see” and attack cancer cells by blocking the proteins that hide tumors from immune recognition.
They have transformed outcomes in melanoma, lung, and bladder cancers, helping the body fight cancer naturally.
Monoclonal Antibodies
Monoclonal antibodies are lab-made immune proteins that specifically attach to cancer cell surfaces.
They can block growth signals or deliver toxic substances directly to tumors, minimizing harm to healthy tissues.
Used in breast, lymphoma, and colorectal cancers with remarkable precision.
.png)
Tyrosine Kinase Inhibitors (TKIs)
TKIs block enzymes that help cancer cells grow and spread.
By stopping these signals, they control tumor growth and often turn cancer into a chronic but manageable condition.
Effective in lung, kidney, and thyroid cancers.
CAR-T Cell Therapy
In this breakthrough treatment, a patient’s own immune cells are genetically modified to recognize and destroy cancer.
CAR-T therapy is showing life-saving results in leukemia, lymphoma, and multiple myeloma, offering a potential cure for some blood cancers.
Genetic and Molecular Oncology
This approach analyzes a tumor’s DNA to determine its specific mutations and vulnerabilities.
Using advanced tests such as Next-Generation Sequencing (NGS) or liquid biopsy, oncologists can personalize therapy — giving the right drug to the right patient at the right time.
Precision Combination Therapies
Modern oncology often combines immunotherapy and targeted drugs to attack cancer from multiple angles.
These tailored regimens maximize effectiveness while reducing the risk of resistance or relapse.
They are increasingly used for advanced solid tumors worldwide.
Supportive and Integrative Care
Nutritional Guidance & Support
Balanced nutrition supports the body’s ability to heal and recover during cancer therapy.
Dietitians personalize meal plans to maintain strength, manage side effects, and improve treatment tolerance.
Psycho-Oncology Support
Emotional well-being is as essential as medical care.
Psychological counseling and therapy help patients cope with fear, stress, and anxiety, improving overall quality of life.
Physical & Stress Rehabilitation
Gentle exercise, physiotherapy, and mindfulness programs help patients regain energy, reduce pain, and rebuild confidence after treatment.
These holistic methods enhance both physical recovery and mental focus.
International Quality and Accreditation
At Maple Med Global, our first criterion in selecting partner hospitals is international accreditation.
We collaborate only with oncology centers that meet the world’s highest standards of clinical safety, ethical governance, and scientific excellence.
Every institution in our network is independently audited and certified by recognized global authorities, ensuring that every patient receives evidence-based, transparent, and patient-centered care.
These accreditations are not symbolic; they represent a hospital’s proven commitment to continuous quality improvement, multidisciplinary decision-making, and advanced safety protocols.
For patients, this means peace of mind: treatments delivered in hospitals that meet the same clinical standards as world-leading cancer institutes in North America and Europe.
JCI is the global benchmark for hospital quality and patient safety, used by major healthcare systems worldwide.
Accreditation requires hospitals to meet over 1,200 measurable standards covering infection control, medication safety, and oncology-specific care pathways.
Only a select group of hospitals achieve JCI certification — each undergoes rigorous on-site inspections every three years.
The OECI Accreditation and Designation Program is Europe’s gold standard for comprehensive cancer centers.
It evaluates hospitals not only for clinical quality but also for their integration of research, education, and patient support services.
OECI-certified centers operate under multidisciplinary tumor boards, ensuring every patient’s treatment is discussed by experts from multiple specialties before decisions are made.
.png)
IASIOS focuses on interventional oncology, covering advanced image-guided therapies such as radioembolization, chemoembolization, and thermal ablation.
Accredited centers must demonstrate excellence in procedural safety, imaging quality, radiation protection, and outcome tracking.
IASIOS is recognized globally as the only dedicated accreditation system that validates quality standards for minimally invasive cancer treatments.
How the Process Works
Maple Med Global is an international medical tourism and healthcare coordination center, helping patients access advanced, reliable, and timely cancer care worldwide.
Every step is designed with scientific precision, transparency, and comprehensive support — ensuring access to the right treatment, at the right time, in the best possible conditions.
1
Medical Review & Second Opinion
Patients’ medical reports and test results are securely shared with accredited oncology departments in the most suitable country or center for their specific condition.
Expert oncologists evaluate each case in detail and prepare an individualized medical assessment, outlining the most appropriate treatment approach and expected outcomes.
A comprehensive second opinion — including a preliminary treatment plan — is typically delivered within two business days, ensuring fast, reliable, and science-based guidance for every patient.
2
Comprehensive and Transparent Proposals
Based on the medical findings, the most appropriate treatment alternatives are identified for each patient.
Thanks to Maple Med Global’s strong partnerships with internationally accredited hospitals, patients benefit from priority access and special institutional pricing advantages.
All costs — excluding flights — are clearly outlined; there are no hidden fees or extra charges.
Each proposal transparently includes all services such as treatment, accommodation, transfers, and translation assistance.
3
4
Treatment and Communication
During treatment, every patient is assisted by a dedicated international patient coordinator.
The Maple Med Global team maintains continuous communication with both the patient and the hospital’s coordination staff, ensuring a transparent and seamless experience from start to finish.
5
Post-Treatment Follow-Up
After treatment, Maple Med Global oversees the patient’s return arrangements and provides continuous post-care support once they are back home.
Follow-up consultations and online doctor check-ins are organized when needed, ensuring the patient’s recovery process is carefully monitored.
Why Choose Maple Med Global
Maple Med Global connects patients to accredited cancer hospitals offering advanced treatments with no waiting times.
Authorized and Patient-Focused Partnerships
Maple Med Global partners with internationally accredited oncology centers that uphold the highest standards of safety and ethics.
Though officially connected with these institutions, we represent the patient’s interests — ensuring objective evaluation and guiding each case toward the safest, most effective, and most affordable treatment.
Experience You Can Trust
With extensive experience in coordinating complex oncology treatments for international patients, Maple Med Global has guided numerous individuals from Canada, the U.S., and Europe through every stage — from diagnosis to recovery.
Our reputation is built on professionalism, compassion, and measurable patient satisfaction.
Personalized Medical Continuity
Every patient is supported by the same dedicated consultant from the first contact to full recovery.
This ensures consistent communication, accurate follow-up, and a sense of trust throughout the entire process.
Global Access & Local Support
Our network spans Europe, Asia, and the Americas, allowing us to recommend destinations that best match each patient’s medical, logistical, and personal needs.
This global approach minimizes waiting times while maintaining world-class standards of care and comfort.
From Our Insights
Explore the latest oncology insights from Maple Med Global — featuring advancements in diagnostics, technology, and global treatment access:
-
Canada’s Healthcare Bottleneck: Why Many Patients Look Abroad for Faster Cancer Care
How Canada’s long waiting times affect cancer outcomes — and why patients are increasingly seeking timely care abroad.
-
Liquid Biopsies: Revolutionizing Early Cancer Detection
How blood-based genomic tests are transforming early detection and personalized treatment in oncology.
-
Advancements in CAR-T Cell Therapy: Personalized Cancer Treatment
Discover how CAR-T immunotherapy is reshaping outcomes for leukemia, lymphoma, and multiple myeloma.
-
Lutetium-177 and Actinium-225: A New Ray of Hope for Prostate Cancer Patients
Learn how theranostic nuclear medicine delivers targeted radiation precisely to cancer cells.
-
Turkey’s Oncology Advantage: Early Detection and Effective Treatment
Why Türkiye has become a global leader in advanced, affordable, and timely cancer care.
-
AI-Powered Lung Cancer Detection: A New Era in Early Diagnosis in Turkey
How artificial intelligence and advanced imaging are helping clinicians identify lung cancer earlier than ever.
-
Robotic Surgery in Turkey: Revolutionizing Healthcare with AI and Precision
Explore how AI-enhanced robotic systems are transforming surgical precision and recovery outcomes in Türkiye.
Get a Free Second Opinion for Cancer Treatment Abroad
Upload your medical reports securely to receive an expert evaluation within 24–48 hours.
Fast, confidential, and entirely free of charge.
info@maplemedglobal.ca
+1 (437) 232-3904
